Abstracts tagged "Biologic agents and biosimilars"

Abstract Number: 220 • 2018 ACR/ARHP Annual Meeting
Non-Medical Switch to Biosimilars: What Have We Learned?
José Marona^1,2, Santiago Rodrigues Manica^1,2, Carina Lopes^1,2, João Lagoas Gomes^1,2, Tiago Costa^1,2, Agna Neto^1,3, Inês Silva^1,2, Ana Filipa Mourão^1,2, Sandra Falcao^1,2, Margarida Mateus⁴, Paula Araújo¹, Walter Castelão¹, Manuela Costa¹, Jaime Cunha Branco^1,2 and Fernando Pimentel-Santos^1,2, ¹Rheumatology, Hospital de Egas Moniz - Centro Hospitalar Lisboa Ocidental, EPE, Lisbon, Portugal, ²CEDOC, NOVA Medical School, Lisbon, Portugal, ³Rheumatology, Hospital Central do Funchal - Serviço de Saúde da Região Autónoma da Madeira, E.P.E, Funchal, Portugal, ⁴Hospital de Egas Moniz - Centro Hospitalar Lisboa Ocidental, EPE, Lisbon, Portugal
Background/Purpose: Biosimilars intend to be as effective and safe as the originator product and would increase patients’ access to biological agents. The decision for switching…